Evidence map›Paper›PMID 36835908›Full record

ReviewJournal of clinical medicine2023

How Radiomics Can Improve Breast Cancer Diagnosis and Treatment.

Filippo Pesapane, Paolo De Marco, Anna Rapino, Eleonora Lombardo, Luca Nicosia, Priyan Tantrige, Anna Rotili, Anna Carla Bozzini, Silvia Penco, Valeria Dominelli and 9 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
15.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Ultrafast Breast MRI: A Narrative Review.Journal of personalized medicine · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Filippo PesapaneBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-0374-5054
Paolo De MarcoMedical Physics Unit, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Anna RapinoPostgraduation School in Radiodiagnostics, University of Milan, 20122 Milan, Italy.
Eleonora LombardoUOC of Diagnostic Imaging, Policlinico Tor Vergata University, 00133 Rome, Italy.
Luca NicosiaBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0003-3979-8075
Priyan TantrigeDepartment of Radiology, King's College Hospital NHS Foundation Trust, London SE5 9RS, UK.ORCID 0000-0001-9366-0785
Anna RotiliBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0001-9439-9275
Anna Carla BozziniBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Silvia PencoBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Valeria DominelliBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Chiara TrentinBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Federica FerrariBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Mariagiorgia FarinaBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Lorenza MeneghettiBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Antuono LatronicoBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Francesca AbbateBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Daniela OriggiMedical Physics Unit, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Gianpaolo CarrafielloDepartment of Radiology, IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Enrico CassanoBreast Imaging Division, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-3437-8939
European Institute of Oncology · ITUniversity of Milan · ITKing's College Hospital NHS Foundation Trust · GBPoliclinico Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent technological advances in the field of artificial intelligence hold promise in addressing medical challenges in breast cancer care, such as early diagnosis, cancer subtype determination and molecular profiling, prediction of lymph node metastases, and prognostication of treatment response and probability of recurrence. Radiomics is a quantitative approach to medical imaging, which aims to enhance the existing data available to clinicians by means of advanced mathematical analysis using artificial intelligence. Various published studies from different fields in imaging have highlighted the potential of radiomics to enhance clinical decision making. In this review, we describe the evolution of AI in breast imaging and its frontiers, focusing on handcrafted and deep learning radiomics. We present a typical workflow of a radiomics analysis and a practical "how-to" guide. Finally, we summarize the methodology and implementation of radiomics in breast cancer, based on the most recent scientific literature to help researchers and clinicians gain fundamental knowledge of this emerging technology. Alongside this, we discuss the current limitations of radiomics and challenges of integration into clinical practice with conceptual consistency, data curation, technical reproducibility, adequate accuracy, and clinical translation. The incorporation of radiomics with clinical, histopathological, and genomic information will enable physicians to move forward to a higher level of personalized management of patients with breast cancer.

Indexed as

artificial intelligencebreast cancermedicinal imagingpersonalized medicinequantitative biomarkersradiomics

Identifiers

PMID36835908
PMCPMC9963325
OpenAlexW4319754535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.